Prevalence and Penetrance of BRCA1 and BRCA2 Gene Mutations in Unselected Ashkenazi Jewish Women With Breast Cancer
about
Founder mutations in BRCA1/2 are not frequent in Canadian Ashkenazi Jewish men with prostate cancerHeritable breast cancer in twinsA single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriersPrevalence of 185delAG and 5382insC mutations in BRCA1, and 6174delT in BRCA2 in women of Ashkenazi Jewish origin in southern BrazilOrigin and distribution of the BRCA2-8765delAG mutation in breast cancerThe prevalence of BRCA1 mutations among young women with triple-negative breast cancer.Current guidelines for BRCA testing of breast cancer patients are insufficient to detect all mutation carriersManagement of familial breast cancer risk.Hereditary breast cancer and handling of patients at risk.Clinical considerations in the management of individuals at risk for hereditary breast and ovarian cancer.Modifiers of risk of hereditary breast and ovarian cancer.Genetics and prevention of pancreatic cancer.Clinical Considerations of BRCA1- and BRCA2-Mutation Carriers: A Review.Importance of hereditary and selected environmental risk factors in the etiology of inflammatory breast cancer: a case-comparison study.Do Breast Cancer Patients Tested in the Oncology Care Setting Share BRCA Mutation Results with Family Members and Health Care Providers?An inherited NBN mutation is associated with poor prognosis prostate cancerProstate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotypeA descriptive study of UK cancer genetics services: an emerging clinical response to the new genetics.Effect of lifestyle and reproductive factors on the onset of breast cancer in female BRCA 1 and 2 mutation carriersCancer risks in first-degree relatives of CHEK2 mutation carriers: effects of mutation type and cancer site in proband.Contribution of BRCA1 germ-line mutations to breast cancer in Greece: a hospital-based study of 987 unselected breast cancer cases.Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from medellín, Colombia.Prostate cancer: germline prediction for a commonly variable malignancy.Prevalence of BRCA mutations among women with triple-negative breast cancer (TNBC) in a genetic counseling cohort.Neo-adjuvant doxorubicin and cyclophosphamide followed by paclitaxel in triple-negative breast cancer among BRCA1 mutation carriers and non-carriers.Perceptions of Ashkenazi Jewish breast cancer patients on genetic testing for mutations in BRCA1 and BRCA2.Prevalence of founder mutations in the BRCA1 and BRCA2 genes among unaffected women from the Bahamas.Screening for germline mutations in breast/ovarian cancer susceptibility genes in high-risk families in Israel.Clinical implications of the breast cancer susceptibility genes BRCA1 and BRCA2.The spectrum of BRCA1 and BRCA2 mutations in breast cancer patients in the Bahamas.Ovarian cancer among 8,005 women from a breast cancer family history clinic: no increased risk of invasive ovarian cancer in families testing negative for BRCA1 and BRCA2.Long-term prospective clinical follow-up after BRCA1/2 presymptomatic testing: BRCA2 risks higher than in adjusted retrospective studies.Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations.Body weight and risk of breast cancer in BRCA1/2 mutation carriers.Cultural aspects of healthy BRCA carriers from two ethnocultural groups.The yield of targeted genotyping for the recurring mutations in BRCA1/2 in Israel.A Survey of BRCA1, BRCA2, and PALB2 mutations in women with breast cancer in Trinidad and Tobago.Prevalence of founder BRCA1 and BRCA2 mutations in unselected French Canadian women with breast cancer.BRCA1 and BRCA2 mutations in Danish families with hereditary breast and/or ovarian cancer.Breast cancer risk in Chinese women with BRCA1 or BRCA2 mutations.
P2860
Q24798248-BF68B397-19C4-439E-B011-72A21D81D265Q28384224-F7D6B761-D252-44EE-8256-4D0B427F53DEQ28387138-11E2002F-75F2-474B-9A55-69F0773128B0Q28389127-731A8FA0-82BD-465A-B530-4BEF9E92782FQ33291268-AADF84DD-0C83-49EC-A22B-0B1BA2129D48Q33419708-368077D8-FDB9-47E2-A840-D9122FC66746Q33823472-DE8FF325-AEDD-478C-A53F-E93E793ACB91Q34034858-7180B6D9-4B88-4DCC-9F68-46F51E401590Q35008189-A3EA8CD3-DB6C-4B02-BEBD-A26938C0DE11Q35039478-1C9ED735-4BCB-40FA-BA2A-02FCCB907C4DQ35084790-0A3EFFC9-5E58-4D31-86DA-EB591754F834Q35641985-1061EB43-6B76-4F70-9BDB-C40E39DE2FC4Q35687632-A708C18C-A955-49BC-BC81-C275021A9845Q36031290-7F908BE6-29BA-4853-9244-303708F28E2CQ36110947-91E63F6B-5927-42E8-AFCE-008FD81FBFBDQ36594121-AD547515-5496-407B-8BCC-CAADA0756420Q36614710-F75093D0-8511-4152-8A49-158999863699Q36623431-AF54A189-7E8A-4692-84C1-F4E1F014BDFAQ36706659-5979CF10-0AA8-47A1-9B1B-E104CD2563B9Q37222641-E40FE04B-34C6-453A-BF19-1AEF5B3CAB49Q37269654-7E7B1812-F5F1-48B5-A535-C1B6C1EF535FQ37721626-97FB0D11-BD3C-4CF2-92A3-36592F3B7ECBQ38043095-4663C415-C08B-4937-8BCA-9A60A9952A4AQ38131418-DFFC5D09-B885-4058-BA49-45B254E31ED9Q38876050-507F7F3B-B020-42A8-8D16-AB209112D4E6Q39429341-90BDD2E1-F392-4A03-89E1-EEE5959AA320Q41004174-9E7CBCD2-55B6-4222-A252-3AB02688F316Q41034563-E694B7DC-FD30-4A5F-AFFE-B195FEEFFB2EQ43267049-E169C71C-FA4C-4F62-B1E9-8D6E942D36DCQ43702401-59EE6F9A-E6BE-4A83-A68B-B188D45DE65AQ43818565-F9EF0EB7-7CFC-4C64-8914-EF6B85916A84Q44508976-91CB1966-950E-4351-9D46-6BF3A1EE6FA5Q44602623-AFA6BFAA-53BA-4C1B-9986-81E5722E9DDFQ47418222-7B20347D-D6FB-411E-B168-3F204C736EFFQ47656975-138B991D-E24C-40BA-B923-5D226636025DQ47686082-B26F6B59-88A2-484F-8D81-C674F8DD3FDBQ48137434-B80B4773-454D-4E0B-BE6B-29EEA063EF83Q49210867-321F1D24-7E16-48DF-BC66-D70E450B113BQ50547545-5BC44348-D6DA-49B7-9CDB-4BBB07333D2DQ50913863-28AF977F-100A-4CF9-AFEC-51DD6F4B0A87
P2860
Prevalence and Penetrance of BRCA1 and BRCA2 Gene Mutations in Unselected Ashkenazi Jewish Women With Breast Cancer
description
article
@en
im Juli 1999 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в липні 1999
@uk
name
Prevalence and Penetrance of B ...... ewish Women With Breast Cancer
@en
Prevalence and Penetrance of B ...... ewish Women With Breast Cancer
@nl
type
label
Prevalence and Penetrance of B ...... ewish Women With Breast Cancer
@en
Prevalence and Penetrance of B ...... ewish Women With Breast Cancer
@nl
prefLabel
Prevalence and Penetrance of B ...... ewish Women With Breast Cancer
@en
Prevalence and Penetrance of B ...... ewish Women With Breast Cancer
@nl
P2093
P2860
P356
P1476
Prevalence and penetrance of B ...... ewish women with breast cancer
@en
P2093
C Paterson
D Allingham-Hawkins
J Honeyford
J S Brunet
P2860
P304
P356
10.1093/JNCI/91.14.1241
P407
P577
1999-07-01T00:00:00Z